Target intelligence / Profile preview

Barrier-to-autointegration factor 1 (BANF1)

Target
BANF1
Molecular classification
Other (non-specific DNA-binding nuclear protein, nuclear envelope-associated structural protein)
01

Overview

Barrier-to-autointegration factor 1 (BANF1) is a highly conserved, small, non-specific DNA-binding protein found in multicellular eukaryotes[1][2][3][4][5]. BANF1 functions as a homodimer, binding to the phosphate backbone of double-stranded DNA and compacting DNA, which helps maintain chromatin organization and genome stability[1][2][3]. It is a critical component of the nuclear envelope, essential for both the assembly and disassembly of the nuclear envelope during cell division[1][2]. BANF1 interacts with key nuclear envelope proteins, including Lamin A, Emerin, and other LEM-domain proteins, anchoring chromatin to the nuclear periphery and regulating nuclear structure[1][2][4]. Loss or mutation of BANF1 leads to loss of nuclear envelope integrity, aberrant chromatin organization, and is genetically linked to the rare premature ageing disorder Néstor–Guillermo Progeria Syndrome (NGPS)[1][2][6]. BANF1 also regulates the DNA repair protein PARP1 and is involved in the DNA damage response, especially in oxidative stress[1][6]. Besides its DNA structural role, BANF1 prevents inappropriate activation of innate immune sensors during nuclear envelope rupture by outcompeting DNA sensors such as cGAS for double-stranded DNA binding[1]. BANF1 is not a typical therapeutic target (i.e., not a receptor, enzyme, transporter, or transcription factor) but is a structural nuclear assembly factor with broad importance in genome maintenance.

Other names
BAFNGPSBCRP1D14S1460barrier-to-autointegration factorBAF nuclear assembly factor 1Breakpoint cluster region protein 1
02

Biological functions

Maintenance of chromatin structureRegulation of genome stabilityNuclear envelope assembly and integrityDNA damage responseCell division (mitotic nuclear reassembly)Regulation of gene expression
03

Disease associations

Premature ageing syndromes (notably Néstor–Guillermo Progeria Syndrome)DNA repair disordersPotential role in muscular dystrophies

Beyond the preview

Go deeper on Barrier-to-autointegration factor 1 (BANF1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Barrier-to-autointegration factor 1 (BANF1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call